Healthcare provider profile · identity verified

Jennifer Bottem, FNP

Nurse Practitioner · SAINT PAUL, MN · NPI 1972579464

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	278	81
Amlodipine Besylate	Amlodipine Besylate	244	74
Rosuvastatin Calcium	Rosuvastatin Calcium	238	69
Levothyroxine Sodium	Levothyroxine Sodium	234	63
Lisinopril	Lisinopril	207	61
Losartan Potassium	Losartan Potassium	183	52
Omeprazole	Omeprazole	167	49
Gabapentin	Gabapentin	142	39
Hydrochlorothiazide	Hydrochlorothiazide	116	32
Trazodone Hcl	Trazodone Hcl	107	34
Simvastatin	Simvastatin	105	31
Bupropion Xl	Bupropion Hcl	101	27
Metoprolol Succinate	Metoprolol Succinate	96	32
Metformin Hcl Er	Metformin Hcl	90	25
Escitalopram Oxalate	Escitalopram Oxalate	89	29
Sertraline Hcl	Sertraline Hcl	85	25
Alendronate Sodium	Alendronate Sodium	84	26
Lorazepam	Lorazepam	67	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	20
Albuterol Sulfate Hfa	Albuterol Sulfate	60	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	55	suppressed
Tizanidine Hcl	Tizanidine Hcl	55	suppressed
Montelukast Sodium	Montelukast Sodium	54	12
Zolpidem Tartrate	Zolpidem Tartrate	53	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	50	14
Duloxetine Hcl	Duloxetine Hcl	49	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	47	suppressed
Alprazolam	Alprazolam	46	12
Jardiance	Empagliflozin	46	13
Carvedilol	Carvedilol	44	11
Fluticasone Propionate	Fluticasone Propionate	43	18
Buspirone Hcl	Buspirone Hcl	41	13
Estradiol	Estradiol	41	14
Pantoprazole Sodium	Pantoprazole Sodium	40	12
Potassium Chloride	Potassium Chloride	39	suppressed
Tramadol Hcl	Tramadol Hcl	39	suppressed
Atenolol	Atenolol	38	suppressed
Allopurinol	Allopurinol	37	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	37	12
Oxycodone Hcl	Oxycodone Hcl	37	suppressed
Ozempic	Semaglutide	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	35	11
Acetaminophen-Codeine	Acetaminophen With Codeine	34	suppressed
Morphine Sulfate Er	Morphine Sulfate	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Propranolol Hcl	Propranolol Hcl	32	suppressed
Valacyclovir	Valacyclovir Hcl	32	14
Famotidine	Famotidine	30	13
Furosemide	Furosemide	30	11
Metformin Hcl	Metformin Hcl	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Mounjaro	Tirzepatide	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Irbesartan	Irbesartan	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Meloxicam	Meloxicam	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	23	suppressed
Pregabalin	Pregabalin	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	11
Valsartan	Valsartan	20	suppressed
Eliquis	Apixaban	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Nystatin	Nystatin	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Torsemide	Torsemide	14	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	14	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Baclofen	Baclofen	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Clopidogrel	Clopidogrel Bisulfate	12	suppressed
Diazepam	Diazepam	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Glipizide	Glipizide	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed
Yuvafem	Estradiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error